IMMY20144/ 64407564MMY1001/ Brea Lipe
Basic Study Information
Purpose:
The purpose of this study is to evaluate the efficacy and safety of talquetamab in
participants with relapsed or refractory multiple myeloma at the recommended Phase
2 dose(s) (RP2Ds) (Part 3).
Location: University of Rochester Medical Center
Lead Researcher (Principal Investigator)
Lead Researcher:
Brea Lipe
Study Contact Information
Study Contact: Clinical Trials Office
Study Location: Wilmot Cancer Institute, University of Rochester Medical Center
Study Email: WCICTOResearch@urmc.rochester.edu
Additional Study Details
Trial Not Found
The study you are looking for is not active at this time.
Return to Search